Hyperthermic isolated limb perfusion increases circulating levels of inflammatory cytokines
Hyperthermic isolated limb perfusion is an established method of treatment for regionally advanced melanoma. Recent studies suggest that exogenously administered cytokines potentiate tumor response in patients with in-transit melanoma. We hypothesized that isolated limb perfusion induces an immunoge...
Saved in:
Published in | Cancer Immunology, Immunotherapy Vol. 40; no. 4; pp. 272 - 275 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Berlin
Springer
01.07.1995
Springer-Verlag |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Hyperthermic isolated limb perfusion is an established method of treatment for regionally advanced melanoma. Recent studies suggest that exogenously administered cytokines potentiate tumor response in patients with in-transit melanoma. We hypothesized that isolated limb perfusion induces an immunogenic response characterized by increased circulating levels of cytokines in the pump circuit, potentially contributing to the antitumor effect. We obtained blood samples from the perfusion circuit and systemic circulation at various intervals from patients undergoing isolated chemotherapeutic perfusion for melanoma. Samples were analyzed for serum cytokine profiles by enzyme-linked immunosorbent assay. When compared with baseline values, significant increases in serum levels of interleukin-6 (IL-6), interleukin-8 (IL-8), and tumor necrosis factor (TNF) occurred within the perfusion circuit during isolated limb perfusion (P < 0.05). In addition, there was a corresponding increase in IL-8 within the systemic circulation at the 60-min interval (P < 0.05), suggesting some degree of leakage from the isolated circuit due to the extremely high levels of IL-8 in the perfusion circuit. A transient but insignificant decrease in circulating levels of neutrophils was also observed during the perfusion process, which may be attributed to margination. Increased levels of cytokines IL-6, IL-8, and TNF occurred within the isolated circuit during hyperthermic limb perfusion and may contribute to tumor response seen in patients treated with isolated limb perfusion. |
---|---|
AbstractList | Hyperthermic isolated limb perfusion is an established method of treatment for regionally advanced melanoma. Recent studies suggest that exogenously administered cytokines potentiate tumor response in patients with in-transit melanoma. We hypothesized that isolated limb perfusion induces an immunogenic response characterized by increased circulating levels of cytokines in the pump circuit, potentially contributing to the antitumor effect. We obtained blood samples from the perfusion circuit and systemic circulation at various intervals from patients undergoing isolated chemotherapeutic perfusion for melanoma. Samples were analyzed for serum cytokine profiles by enzyme-linked immunosorbent assay. When compared with baseline values, significant increases in serum levels of interleukin-6 (IL-6), interleukin-8 (IL-8), and tumor necrosis factor (TNF) occurred within the perfusion circuit during isolated limb perfusion (P < 0.05). In addition, there was a corresponding increase in IL-8 within the systemic circulation at the 60-min interval (P < 0.05), suggesting some degree of leakage from the isolated circuit due to the extremely high levels of IL-8 in the perfusion circuit. A transient but insignificant decrease in circulating levels of neutrophils was also observed during the perfusion process, which may be attributed to margination. Increased levels of cytokines IL-6, IL-8, and TNF occurred within the isolated circuit during hyperthermic limb perfusion and may contribute to tumor response seen in patients treated with isolated limb perfusion. Hyperthermic isolated limb perfusion is an established method of treatment for regionally advanced melanoma. Recent studies suggest that exogenously administered cytokines potentiate tumor response in patients with in-transit melanoma. We hypothesized that isolated limb perfusion induces an immunogenic response characterized by increased circulating levels of cytokines in the pump circuit, potentially contributing to the antitumor effect. We obtained blood samples from the perfusion circuit and systemic circulation at various intervals from patients undergoing isolated chemotherapeutic perfusion for melanoma. Samples were analyzed for serum cytokine profiles by enzyme-linked immunosorbent assay. When compared with baseline values, significant increases in serum levels of interleukin-6 (IL-6), interleukin-8 (IL-8), and tumor necrosis factor (TNF) occurred within the perfusion circuit during isolated limb perfusion ( P <0.05). In addition, there was a corresponding increase in IL-8 within the systemic circulation at the 60-min interval ( P <0.05), suggesting some degree of leakage from the isolated circuit due to the extremely high levels of IL-8 in the perfusion circuit. A transient but insignificant decrease in circulating levels of neutrophils was also observed during the perfusion process, which may be attributed to margination. Increased levels of cytokines IL-6, IL-8, and TNF occurred within the isolated circuit during hyperthermic limb perfusion and may contribute to tumor response seen in patients treated with isolated limb perfusion. |
Author | QUINN, T. D EDWARDS, M. J POLK, J. C |
Author_xml | – sequence: 1 givenname: T. D surname: QUINN fullname: QUINN, T. D organization: Univ. Louisville, dep. surgery, div. surgical oncology, Louisville KY 40292, United States – sequence: 2 givenname: J. C surname: POLK fullname: POLK, J. C organization: Univ. Louisville, dep. surgery, div. surgical oncology, Louisville KY 40292, United States – sequence: 3 givenname: M. J surname: EDWARDS fullname: EDWARDS, M. J organization: Univ. Louisville, dep. surgery, div. surgical oncology, Louisville KY 40292, United States |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3517879$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/7750126$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkEFLxDAQRoOs6Lp68S704EmoTtK0aU-ii7qC4MWbhzLNTjTaJkvSXei_t-Ky6mkG3ptv4DtiE-cdMXbK4ZIDqKvbe-A5ryoQe2zKZSZSKHM-YVPIJKQKQB6yoxg_xkVAVR2wA6Vy4KKYstfFsKLQv1PorE5s9C32tExa2zXJCMw6Wu8S63QgjBQTbYNej451b0lLG2pj4s3ITYtdh70PQ6KH3n9aR_GY7RtsI51s54y93N-9zBfp0_PD4_zmKdVZofqUeJGrRmVQSqywlEZJI1GLQjcGSwFYASI2kgRIBZKWy4ag0UKWXBlqshm7_oldrZuOlppcH7CtV8F2GIbao63_E2ff6ze_qTmHTBUVjAkXPwk6-BgDmd0xh_q74fq34VE--_tup24rHfn5lmPU2JqATtu407Kcq1JV2RdscohE |
CODEN | CIIMDN |
CitedBy_id | crossref_primary_10_1002__SICI_1097_0142_19970315_79_6_1129__AID_CNCR11_3_0_CO_2_1 crossref_primary_10_1097_00002371_200107000_00011 crossref_primary_10_1200_JCO_2002_01_003 crossref_primary_10_1002__SICI_1096_9098_199903_70_3_185__AID_JSO8_3_0_CO_2 crossref_primary_10_1016_S0003_4975_97_00506_7 crossref_primary_10_1053_ejso_1999_0687 |
Cites_doi | 10.1200/JCO.1991.9.12.2091 10.1016/S0021-9258(18)37790-1 10.1016/0003-4975(92)91446-G 10.1016/0140-6736(93)90416-E 10.1016/0002-9610(65)90076-0 10.4049/jimmunol.142.3.808 10.1200/JCO.1992.10.1.52 10.1093/ajcp/66.5.840 10.1097/00000658-195810000-00009 10.1042/bj2650621 10.1016/0014-5793(89)80476-4 10.1016/S0041-008X(71)80026-1 10.1172/JCI112721 10.1001/archsurg.1990.01410150039008 10.1146/annurev.bi.57.070188.002445 10.1016/0006-2952(72)90384-X 10.1002/1097-0142(19860515)57:10<1923::AID-CNCR2820571006>3.0.CO;2-E |
ContentType | Journal Article |
Copyright | 1995 INIST-CNRS Springer-Verlag 1995 |
Copyright_xml | – notice: 1995 INIST-CNRS – notice: Springer-Verlag 1995 |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 5PM |
DOI | 10.1007/BF01519902 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1432-0851 |
EndPage | 275 |
ExternalDocumentID | 10_1007_BF01519902 7750126 3517879 |
Genre | Research Support, Non-U.S. Gov't Journal Article Comparative Study |
GroupedDBID | --- -53 -56 -5G -BR -EM -Y2 -~C .55 .86 .VR 06C 06D 0R~ 0VY 199 1N0 1SB 2.D 203 28- 29B 29~ 2J2 2JN 2JY 2KG 2KM 2LR 2P1 2VQ 2~H 30V 36B 3V. 4.4 406 408 409 40D 40E 53G 5GY 5QI 5RE 5VS 67Z 6J9 6NX 78A 7X7 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8TC 8UJ 95- 95. 95~ 96X AAAVM AABHQ AABYN AAFGU AAHNG AAIAL AAJKR AAKSU AANXM AANZL AAPBV AARHV AARTL AATNV AATVU AAUGY AAUYE AAWCG AAYFA AAYIU AAYQN AAYTO ABBBX ABBXA ABDZT ABECU ABFGW ABFTV ABHLI ABHQN ABIPD ABJOX ABKAS ABKCH ABKTR ABMNI ABMQK ABNWP ABPLI ABPTK ABQBU ABSXP ABTEG ABTKH ABTMW ABULA ABUWG ABUWZ ABWNU ABXPI ACBMV ACBRV ACBXY ACBYP ACGFS ACHSB ACHVE ACHXU ACIGE ACIHN ACIPQ ACKNC ACMDZ ACMLO ACOKC ACOMO ACPRK ACREN ACTTH ACUDM ACVWB ACWMK ADBBV ADHHG ADHIR ADIMF ADINQ ADJJI ADKNI ADKPE ADMDM ADOXG ADRFC ADTPH ADURQ ADYFF ADYOE ADZKW AEAQA AEBTG AEEQQ AEFIE AEFTE AEGAL AEGNC AEJHL AEJRE AEKMD AENEX AEOHA AEPYU AESKC AESTI AETLH AEVLU AEVTX AEXYK AFAFS AFEXP AFJLC AFKRA AFLOW AFNRJ AFQWF AFWTZ AFYQB AFZKB AGAYW AGDGC AGGBP AGGDS AGJBK AGKHE AGMZJ AGQMX AGWIL AGWZB AGYKE AHAVH AHBYD AHIZS AHKAY AHMBA AHSBF AHYZX AIAKS AIIXL AILAN AIMYW AITGF AJBLW AJDOV AJRNO AJZVZ AKMHD AKQUC ALMA_UNASSIGNED_HOLDINGS ALWAN AMKLP AMTXH AMXSW AMYLF AMYQR AOCGG ARMRJ ASPBG AVWKF AXYYD AZFZN B-. BA0 BBNVY BBWZM BDATZ BENPR BGNMA BHPHI BPHCQ BVXVI CAG CCPQU COF CSCUP DDRTE DL5 DNIVK DPUIP DU5 EBD EBLON EBS EIOEI EJD EMB EMOBN EN4 ESBYG F5P FEDTE FERAY FFXSO FIGPU FINBP FNLPD FRRFC FSGXE FWDCC FYUFA G-Y G-Z GGCAI GGRSB GJIRD GNWQR GQ6 GQ7 GQ8 GRRUI GXS H13 HCIFZ HF~ HG5 HG6 HMJXF HQYDN HRMNR HZ~ I09 IH2 IHE IJ- IKXTQ IMOTQ IQODW ITM IWAJR IXC IZIGR IZQ I~X I~Z J-C J0Z JBSCW JCJTX JZLTJ KDC KOV KOW KPH LAS LK8 LLZTM M1P M4Y M7P MA- N2Q N9A NB0 NDZJH NPVJJ NQJWS NU0 O9- O93 O9G O9I O9J OAM P19 P2P P9S PF0 PQQKQ PROAC PSQYO PT4 PT5 Q2X QOK QOR QOS R4E R89 R9I RHV RNI ROL RPX RSV RZK S16 S1Z S26 S27 S28 S37 S3B SAP SBL SCLPG SDE SDH SDM SHX SISQX SJYHP SNE SNPRN SNX SOHCF SOJ SPISZ SRMVM SSLCW SSXJD STPWE SV3 SZ9 SZN T13 T16 TSG TSK TSV TT1 TUC U2A U9L UDS UG4 UKHRP UNUBA UOJIU UTJUX UZXMN VC2 VFIZW W23 W48 WJK WK8 X7M YLTOR Z45 Z7U Z7V Z7X Z82 Z83 Z84 Z87 Z8O Z8P Z8V Z8W Z8Y Z91 ZGI ZMTXR ZOVNA ~EX ~KM AAEOY AAKKN AAYZH ABAKF ABEEZ ABJNI ACACY ACULB ACZOJ AEFQL AFBBN AFGXO AGQEE AGRTI AJOOF ALIPV C24 C6C CGR CUY CVF ECM EIF HMCUK HVGLF NPM RPM AAYXX CITATION 5PM |
ID | FETCH-LOGICAL-c367t-e1657b73084a9a84f74f4ac26cbfa820a90aaab4e204704eddbe0bc24817feb3 |
IEDL.DBID | RPM |
ISSN | 0340-7004 |
IngestDate | Tue Sep 17 21:28:18 EDT 2024 Thu Sep 12 18:50:15 EDT 2024 Sat Nov 02 12:05:47 EDT 2024 Sun Oct 29 17:07:31 EDT 2023 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Keywords | Antineoplastic agent Regional treatment Cytokine Melanoma Malignant tumor Interleukin 6 Local administration Chemotherapy Perfusion Limb Advanced stage Combined treatment Tumor necrosis factor α Induced hyperthermia Interleukin 8 |
Language | English |
License | CC BY 4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c367t-e1657b73084a9a84f74f4ac26cbfa820a90aaab4e204704eddbe0bc24817feb3 |
PMID | 7750126 |
PageCount | 4 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_11037690 crossref_primary_10_1007_BF01519902 pubmed_primary_7750126 pascalfrancis_primary_3517879 |
PublicationCentury | 1900 |
PublicationDate | 1995-07-00 |
PublicationDateYYYYMMDD | 1995-07-01 |
PublicationDate_xml | – month: 07 year: 1995 text: 1995-07-00 |
PublicationDecade | 1990 |
PublicationPlace | Berlin |
PublicationPlace_xml | – name: Berlin – name: Germany – name: Berlin/Heidelberg |
PublicationTitle | Cancer Immunology, Immunotherapy |
PublicationTitleAlternate | Cancer Immunol Immunother |
PublicationYear | 1995 |
Publisher | Springer Springer-Verlag |
Publisher_xml | – name: Springer – name: Springer-Verlag |
References | J Le (BF01519902_CR14) 1989; 61 L Hafström (BF01519902_CR11) 1991; 9 H Martijn (BF01519902_CR18) 1986; 57 MJ Edwards (BF01519902_CR8) 1990; 125 G Morrone (BF01519902_CR21) 1988; 263 FR Balkwill (BF01519902_CR1) 1986; 46 CH Wortel (BF01519902_CR28) 1993; 114 P Calabresi (BF01519902_CR4) 1990 BF01519902_CR20 JV Castell (BF01519902_CR5) 1989; 242 PP Saunders (BF01519902_CR23) 1974; 34 AT Lefor (BF01519902_CR15) 1994; 116 JS Stehlin (BF01519902_CR25) 1965; 110 PC Heinrich (BF01519902_CR12) 1990; 265 SC Donnelly (BF01519902_CR7) 1993; 341 S Marinkovic (BF01519902_CR17) 1989; 142 J Butler (BF01519902_CR3) 1992; 53 M Vaglini (BF01519902_CR27) 1987; 13 B Beutler (BF01519902_CR2) 1988; 57 AH Gerulath (BF01519902_CR10) 1972; 21 O Creech Jr (BF01519902_CR6) 1958; 148 C Fischer (BF01519902_CR9) 1976; 66 ET Krementz (BF01519902_CR13) 1985 D Lienard (BF01519902_CR16) 1992; 10 JS Stehlin (BF01519902_CR26) 1975; 140 NS Mizuno (BF01519902_CR19) 1972; 56 DH Perlmutter (BF01519902_CR22) 1986; 78 JL Skibba (BF01519902_CR24) 1971; 18 |
References_xml | – volume: 9 start-page: 2091 year: 1991 ident: BF01519902_CR11 publication-title: J Clin Oncol doi: 10.1200/JCO.1991.9.12.2091 contributor: fullname: L Hafström – volume: 263 start-page: 12554 year: 1988 ident: BF01519902_CR21 publication-title: J Biol Chem doi: 10.1016/S0021-9258(18)37790-1 contributor: fullname: G Morrone – volume: 140 start-page: 339 year: 1975 ident: BF01519902_CR26 publication-title: Surg Gynecol Obstet contributor: fullname: JS Stehlin – start-page: 1209 volume-title: The pharmacological basis of therapeutics year: 1990 ident: BF01519902_CR4 contributor: fullname: P Calabresi – volume: 53 start-page: 833 year: 1992 ident: BF01519902_CR3 publication-title: Ann Thorac Surg doi: 10.1016/0003-4975(92)91446-G contributor: fullname: J Butler – volume: 341 start-page: 643 year: 1993 ident: BF01519902_CR7 publication-title: Lancet doi: 10.1016/0140-6736(93)90416-E contributor: fullname: SC Donnelly – volume: 56 start-page: 465 year: 1972 ident: BF01519902_CR19 publication-title: Cancer Chemother Rep contributor: fullname: NS Mizuno – volume: 110 start-page: 366 year: 1965 ident: BF01519902_CR25 publication-title: Am J Surg doi: 10.1016/0002-9610(65)90076-0 contributor: fullname: JS Stehlin – volume: 142 start-page: 808 year: 1989 ident: BF01519902_CR17 publication-title: J Immunol doi: 10.4049/jimmunol.142.3.808 contributor: fullname: S Marinkovic – volume: 10 start-page: 52 year: 1992 ident: BF01519902_CR16 publication-title: J Clin Oncol doi: 10.1200/JCO.1992.10.1.52 contributor: fullname: D Lienard – volume: 66 start-page: 840 year: 1976 ident: BF01519902_CR9 publication-title: Am J Clin Pathol doi: 10.1093/ajcp/66.5.840 contributor: fullname: C Fischer – volume: 116 start-page: 214 year: 1994 ident: BF01519902_CR15 publication-title: Surgery contributor: fullname: AT Lefor – volume: 148 start-page: 616 year: 1958 ident: BF01519902_CR6 publication-title: Ann Surg doi: 10.1097/00000658-195810000-00009 contributor: fullname: O Creech Jr – volume: 265 start-page: 621 year: 1990 ident: BF01519902_CR12 publication-title: Biochem J doi: 10.1042/bj2650621 contributor: fullname: PC Heinrich – volume: 114 start-page: 564 year: 1993 ident: BF01519902_CR28 publication-title: Surgery contributor: fullname: CH Wortel – start-page: 171 volume-title: Cutaneous melanoma: clinical management and treatment results worldwide year: 1985 ident: BF01519902_CR13 contributor: fullname: ET Krementz – volume: 13 start-page: 127 year: 1987 ident: BF01519902_CR27 publication-title: Eur J Surg Oncol contributor: fullname: M Vaglini – volume: 46 start-page: 3990 year: 1986 ident: BF01519902_CR1 publication-title: Cancer Res contributor: fullname: FR Balkwill – volume: 242 start-page: 237 year: 1989 ident: BF01519902_CR5 publication-title: FEBS Lett doi: 10.1016/0014-5793(89)80476-4 contributor: fullname: JV Castell – volume: 18 start-page: 707 year: 1971 ident: BF01519902_CR24 publication-title: Toxicol Appl Pharmacol doi: 10.1016/S0041-008X(71)80026-1 contributor: fullname: JL Skibba – volume: 78 start-page: 1349 year: 1986 ident: BF01519902_CR22 publication-title: J Clin Invest doi: 10.1172/JCI112721 contributor: fullname: DH Perlmutter – volume: 125 start-page: 317 year: 1990 ident: BF01519902_CR8 publication-title: Arch Surg doi: 10.1001/archsurg.1990.01410150039008 contributor: fullname: MJ Edwards – ident: BF01519902_CR20 – volume: 57 start-page: 505 year: 1988 ident: BF01519902_CR2 publication-title: Annu Rev Biochem doi: 10.1146/annurev.bi.57.070188.002445 contributor: fullname: B Beutler – volume: 61 start-page: 588 year: 1989 ident: BF01519902_CR14 publication-title: Lab Invest contributor: fullname: J Le – volume: 34 start-page: 2464 year: 1974 ident: BF01519902_CR23 publication-title: Cancer Res contributor: fullname: PP Saunders – volume: 21 start-page: 2335 year: 1972 ident: BF01519902_CR10 publication-title: Biochem Pharmacol doi: 10.1016/0006-2952(72)90384-X contributor: fullname: AH Gerulath – volume: 57 start-page: 1923 year: 1986 ident: BF01519902_CR18 publication-title: Cancer doi: 10.1002/1097-0142(19860515)57:10<1923::AID-CNCR2820571006>3.0.CO;2-E contributor: fullname: H Martijn |
SSID | ssj0042099 ssj0001254 |
Score | 1.5393668 |
Snippet | Hyperthermic isolated limb perfusion is an established method of treatment for regionally advanced melanoma. Recent studies suggest that exogenously... |
SourceID | pubmedcentral crossref pubmed pascalfrancis |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | 272 |
SubjectTerms | Antineoplastic agents Antineoplastic Combined Chemotherapy Protocols - administration & dosage Biological and medical sciences Chemotherapy, Cancer, Regional Perfusion Combined Modality Therapy Combined treatments (chemotherapy of immunotherapy associated with an other treatment) Cytokines - blood Dactinomycin - administration & dosage Drug Administration Schedule Extremities Humans Hyperthermia, Induced Inflammation - blood Inflammation - etiology Infusion Pumps Mechlorethamine - administration & dosage Medical sciences Melanoma - blood Melanoma - therapy Pharmacology. Drug treatments Short Communication |
Title | Hyperthermic isolated limb perfusion increases circulating levels of inflammatory cytokines |
URI | https://www.ncbi.nlm.nih.gov/pubmed/7750126 https://pubmed.ncbi.nlm.nih.gov/PMC11037690 |
Volume | 40 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LS8NAEB7aglIQ8VWsWlnQa9o8NpvkKMVShIqHCgUPZXezq8EmLU178N87mzS1uXpMJoEw-XZnZuebGYBHhEnAfSUtEQtmUYdrXHOeb-lQonVSzPaKcW-TVzZ-py8zf9YAVtXCFKR9KZJ-tkj7WfJVcCtXqRxUPLHB22TomOI2DOsGTWgiQqsYvV2drBgLWV5QUxlaJBIMcQ6v6x1K0dzhbuy24ShAy-mYDgsH1ulkxXNUlC4nXByYqDp98sAejc7gdOdIkqfyg8-hobILOJ7sUuWX8DHGCHNt3Ls0kSRBiKFXGZNFkgqCAr01x2QkyYzXmKucyGQti1Fe2SdZGCZRTpYa5RohkxapeCJ_NstvQ5O_gunoeTocW7tJCpb0WLCxlMP8QKCqQsojHlIdUE25dJkUmqMPwCObcy6ocm0a2FTFsVC2kC4NnUBjuN2BVrbM1DUQyRnXPvMkFRE1Sc4Qb3iRjKgb43q2u_BQKXC-KvtlzKvOyH8K70Kvptv9o57v4A4SdaFTqngv2P2fLoQ13e_lpkt2XYLgKbplV2C5-f-rt9AuK9kNS_cOWpv1VvXQF9mI-wJ6v21Q3uY |
link.rule.ids | 230,315,730,783,787,888,27936,27937,53804,53806 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT8MwDLbGEDAJIZ5iwCASXMv6SNP2iBDTgA1xGNIkDlOSJlCxdtM2Dvx7nHYd65Vj6laqHDu24882wA2KScB9JS0RC2ZRh2vUOc-3dCjROilme_m4t_4L677Rp6E_rAEra2Fy0L4UyW02Tm-z5DPHVk5T2S5xYu3X_r1jitswrGtvwCYqrE3LKL1R3q0YG1ksqKkNzVMJBjqH62qPUjR4eB67DdgK0HY6psfCmn3anfI5skoXMy7WjFQVQLlmkTr7sLd0Jcld8csHUFPZIWz3l8nyI3jvYow5Mw5emkiSoJChXxmTcZIKggT9bS7KSJIZv3Gu5kQmM5kP88o-yNhgieZkopGuUWjSPBlP5M9i8mWA8scw6DwM7rvWcpaCJT0WLCzlMD8QqM4h5REPqQ6oply6TArN0Qvgkc05F1S5Ng1squJYKFtIl4ZOoDHgPoF6NsnUKRDJGdc-8yQVETVpzhAfeJGMqBujRttNuC4ZOJoWHTNGZW_kP4Y3oVXh7epVz3fwDImacFKweEVY7k8TwgrvV3TTJ7tKQfHJ-2WX4nL2_0-vYKc76PdGvceX53NoFHXtBrN7AfXF7Fu10DNZiMtcDH8BUqbiPA |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT8MwDLZ4CDQJIZ5iwCASXMv6SNP2iAbTeAxxAAmJw5SkCVSs3bSOA_8ep4-xXjm2bqXKtfPZ8Rcb4BLNJOC-kpaIBbOowzX6nOdbOpSITorZXjHubfjEBq_0_s1_q1iVeUWrzKRIrrJxepUlnwW3cprKbs0T6z4Pe4453IZpXXca6-4qrKPT2qzO1Fv1_orByfKCmvOhRTnB0OfwutmnFEEP12S3BRsB4qdj-iwsYdTWlOeoLl3OuVgCqiaJcgmV-juwXYWT5Lr87F1YUdkebA6rgvk-vA8wz5yZIC9NJEnQ0DC2jMk4SQVBgf42m2UkyUzsmKucyGQmi4Fe2QcZGz5RTiYa5RoNJy0K8kT-zCdfhix_AC_925fewKrmKVjSY8HcUg7zA4EuHVIe8ZDqgGrKpcuk0BwjAR7ZnHNBlWvTwKYqjoWyhXRp6AQak-5DWMsmmToCIjnj2meepCKiptQZ4g0vkhF1Y_Rquw0XtQJH07Jrxqjuj_yn8DZ0GrpdPOr5Dq4jURsOSxUvBNX_aUPY0P1CbnplNyVoQkXP7Npkjv__6jlsPt_0R493Tw8n0CqPthva7imszWffqoPByVycFVb4C5y0408 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hyperthermic+isolated+limb+perfusion+increases+circulating+levels+of+inflammatory+cytokines&rft.jtitle=Cancer+Immunology%2C+Immunotherapy&rft.au=Quinn%2C+Terre+D.&rft.au=Polk%2C+Hiram+C.&rft.au=Edwards%2C+Michael+J.&rft.date=1995-07-01&rft.issn=0340-7004&rft.eissn=1432-0851&rft.volume=40&rft.issue=4&rft.spage=272&rft.epage=275&rft_id=info:doi/10.1007%2FBF01519902&rft.externalDBID=n%2Fa&rft.externalDocID=10_1007_BF01519902 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0340-7004&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0340-7004&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0340-7004&client=summon |